Abstract 4138210: In-hospital Mortality and Cardiovascular Complications in Acute Pericarditis among patients with Heart Failure with Preserved Ejection Fraction

Background: Heart failure with preserved ejection fraction (HFpEF), often referred to as diastolic heart failure, presents significant treatment challenges. Acute pericarditis (AP) is a life-threatening illness, yet the literature on its epidemiology and outcomes in HFpEF patients is scarce. Hypothesis: Acute pericarditis in HFpEF patients is associated with increased risks of myocardial infarction, various types of heart block, cardiac tamponade, ventricular arrhythmia, cardiogenic shock, and in-hospital mortality. Aim: This study aims to outline the association of major cardiovascular outcomes with acute pericarditis in hospitalized HFpEF patients. Methods: A retrospective observational cohort study was conducted using the National Inpatient Sample from 2016 to 2020. We included patients with documented AP among those with HFpEF, identified using validated ICD-10 codes. Univariate and multivariate logistic regression analyses identified outcomes and adjusted for potential confounders using the Elixhauser comorbidity index. Results: Among 471,145 hospitalized HFpEF patients, approximately 424 (0.09%) had AP between 2016 and 2020. The mean age was 67, predominantly female (58%), with a mean length of stay (LOS) of 8 days. Among patients with HFpEF, increased cardiovascular complications were associated with AP, including heart block in 5% of patients (OR = 1.3, 95% CI 1.1 to 1.6, p = 0.002), cardiac arrest in 2.3% (OR = 1.6, 95% CI 1.2 to 2.1, p < 0.001), and myocardial infarction in 4.5% of patients (OR = 1.3, 95% CI 1.1 to 1.6, p = 0.015). Ventricular arrhythmias occurred in 2.4% (OR = 1.5, 95% CI 1.2 to 1.9, p < 0.001), cardiogenic shock in 0.39% (OR = 5.4, 95% CI 4.3 to 6.8, p < 0.001), cardiac tamponade in 16.5% (OR = 144, 95% CI 127.2 to 164, p < 0.001), and mortality was 4.25%. However, the association between AP and mortality was not statistically significant (OR = 2.4, p = 0.152) (see Figure 1). Conclusion: Acute pericarditis, while rare in HFpEF patients, is associated with increased major cardiovascular complications, including ventricular arrhythmias, tamponade, cardiogenic shock, and cardiac arrest, particularly with a significant odds ratio for cardiac tamponade.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2024-11-12
DOI
https://doi.org/10.1161/circ.150.suppl_1.4138210
Primary Topic
Pericarditis and Cardiac Tamponade
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4138210: In-hospital Mortality and Cardiovascular Complications in Acute Pericarditis among patients with Heart Failure with Preserved Ejection Fraction

Henry Aiwuyo, Jamal Perry, Emmanuel Ukenenye, Charles Poluyi et al.
Circulation
Pericarditis and Cardiac Tamponade
article

Abstract 4138210: In-hospital Mortality and Cardiovascular Complications in Acute Pericarditis among patients with Heart Failure with Preserved Ejection Fraction

Henry Aiwuyo, Jamal Perry, Emmanuel Ukenenye, Charles Poluyi, Oluwasegun Akinti, Esther Duodu
article en

Abstract

Background: Heart failure with preserved ejection fraction (HFpEF), often referred to as diastolic heart failure, presents significant treatment challenges. Acute pericarditis (AP) is a life-threatening illness, yet the literature on its epidemiology and outcomes in HFpEF patients is scarce. Hypothesis: Acute pericarditis in HFpEF patients is associated with increased risks of myocardial infarction, various types of heart block, cardiac tamponade, ventricular arrhythmia, cardiogenic shock, and in-hospital mortality. Aim: This study aims to outline the association of major cardiovascular outcomes with acute pericarditis in hospitalized HFpEF patients. Methods: A retrospective observational cohort study was conducted using the National Inpatient Sample from 2016 to 2020. We included patients with documented AP among those with HFpEF, identified using validated ICD-10 codes. Univariate and multivariate logistic regression analyses identified outcomes and adjusted for potential confounders using the Elixhauser comorbidity index. Results: Among 471,145 hospitalized HFpEF patients, approximately 424 (0.09%) had AP between 2016 and 2020. The mean age was 67, predominantly female (58%), with a mean length of stay (LOS) of 8 days. Among patients with HFpEF, increased cardiovascular complications were associated with AP, including heart block in 5% of patients (OR = 1.3, 95% CI 1.1 to 1.6, p = 0.002), cardiac arrest in 2.3% (OR = 1.6, 95% CI 1.2 to 2.1, p < 0.001), and myocardial infarction in 4.5% of patients (OR = 1.3, 95% CI 1.1 to 1.6, p = 0.015). Ventricular arrhythmias occurred in 2.4% (OR = 1.5, 95% CI 1.2 to 1.9, p < 0.001), cardiogenic shock in 0.39% (OR = 5.4, 95% CI 4.3 to 6.8, p < 0.001), cardiac tamponade in 16.5% (OR = 144, 95% CI 127.2 to 164, p < 0.001), and mortality was 4.25%. However, the association between AP and mortality was not statistically significant (OR = 2.4, p = 0.152) (see Figure 1). Conclusion: Acute pericarditis, while rare in HFpEF patients, is associated with increased major cardiovascular complications, including ventricular arrhythmias, tamponade, cardiogenic shock, and cardiac arrest, particularly with a significant odds ratio for cardiac tamponade.

CirculationVol. 150(Suppl_1)
Brookdale University Hospital and Medical Center (US)
Good health and well-being
Openalex Percentile: Top 62%
Pericarditis and Cardiac Tamponade
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.